Peripheral IV therapy is one of the most common procedures in healthcare — yet it comes with a hidden risk. Infiltrations and extravasations (PIVIEs) can lead to complications ranging from swelling and pain to severe tissue damage, extended hospital stays, and even surgical intervention. While every patient with an IV is vulnerable, some care environments carry significantly higher risk: the neonatal intensive care unit (NICU), oncology wards, and intensive care units (ICUs).
In these settings, continuous monitoring is not a “nice-to-have.” It’s an essential layer of protection for patients and clinicians alike.
The Challenge of Intermittent Assessments
The current standard of care relies on clinicians performing routine IV site checks — assessing for swelling, warmth, pain, and changes in skin condition. But this approach has limitations:
- Subjectivity: Different clinicians may interpret site changes differently.
- Visibility: IV sites may be covered by drapes, dressings, or equipment.
- Communication Barriers: Infants, sedated patients, or those with impaired communication can’t report discomfort.
- Staffing Pressures: Nurse-to-patient ratios, especially in high-acuity units, limit how frequently assessments can be performed.
These challenges are magnified in high-risk populations.
NICU: Protecting the Most Vulnerable
Premature and low-birth-weight infants have fragile veins and underdeveloped skin and tissue, making them especially prone to IV complications. PIVIEs in neonates may not only cause local tissue injury but also impact long-term limb development and increase the risk of infection.
Continuous monitoring in the NICU enables early detection before visible signs appear, allowing clinicians to intervene when infiltrations are still minor and prevent lifelong consequences.
Oncology: Managing Vesicant and Irritant Risk
Cancer therapies often involve costly, vesicant or irritant infusions — drugs that can cause significant tissue necrosis if they leak outside the vein. Even a small infiltration can escalate quickly, leading to surgery, permanent disability, or interruption of critical treatment.
Continuous monitoring provides a second set of eyes during chemotherapy infusions, detecting tissue changes in real time and alerting staff before severe extravasation occurs. For oncology patients already enduring aggressive therapies, this added protection can mean avoiding preventable harm and preserving quality of life.
ICU: Complexity and Limited Access
In intensive care units, patients are often sedated, immobile, or surrounded by life-sustaining equipment. IV sites may be tucked under drapes or difficult to reach for routine checks. At the same time, ICU patients frequently require multiple continuous infusions, making every vascular access site both critical and difficult to replace.
A growing trend is the administration of vasopressors through peripheral IV lines, particularly during emergent stabilization or when central access is delayed. While this practice can be lifesaving, it heightens the stakes — vasopressors are potent agents that can cause severe tissue injury if extravasation occurs, even in the smallest amounts of fluid leaking outside the vein.
Continuous monitoring provides ICU clinicians with confidence if the IV is patent or not, directly at the bedside. By detecting early tissue changes, it helps reduce reliance on intermittent checks, supports safer use of peripheral vasopressors, and ensures that infiltrations are identified before they escalate to serious harm.
How ivWatch Changes the Standard of Care
The ivWatch system uses an optical sensor and a predictive algorithm to continuously monitor the tissue around an IV site. Instead of relying solely on subjective checks, clinicians gain real-time alerts to the earliest signs of infiltration. This technology:
- Detects complications before clinically visible symptoms manifest
- Supports consistent, objective surveillance across all shifts
- Helps downgrade injuries from severe (Grade 3–4) to minor (Grade 1–2)
- Protects patients in the most vulnerable, high-risk environments
Because when you catch problems early—you change outcomes completely.
Moving From Reactive to Proactive
In high-risk units, time is critical. Every delay in detecting an infiltration increases the chance of severe harm. Continuous monitoring shifts IV care from reactive detection to proactive prevention, aligning with hospitals’ broader patient safety goals.